David Steinberg is the Chief Innovation Officer at PureTech Health. As a member of PureTech Health, Mr. Steinberg has led the development of a number of programs, including Vedanta Biosciences, Entrega Biosciences, Vor Biopharma, and Commense Health. He is a co-founder of resTORbio and also served as Chief Business Officer of Follica, Inc.
Previously, Mr. Steinberg was a strategy consultant with the Boston Consulting Group and Vertex Partners, focusing on R&D and product strategy and strategic alliances for Fortune 500 pharmaceutical and biotechnology clients.
Mr. Steinberg also worked as a research associate in Procter and Gamble Pharmaceuticals' R&D organization. He received his BA in Biology with distinction from Cornell University and graduated with high honors from the University of Chicago Booth School of Business with an MBA in Strategy and Finance. Mr. Steinberg is also a member of the UChicago Tech Innovation Fund Advisory Committee.